Cleveland Clinic Cancer Advances
Cleveland Clinic Taussig Cancer Institute
Subscribe
A Cleveland Clinic podcast for medical professionals exploring the latest innovative research and clinical advances in the field of oncology.
Available episodes
Newest first
Oldest first
May 18, 2023
Monoclonal Gammopathy of Undetermined Significance (MGUS)
Sandra Mazzoni, DO, a hematologist at Cleveland Clinic Taussig Cancer Institute joins the Cancer Advances podcast to talk about monoclonal gammopathy of undetermined significance, known as MGUS. Listen as Dr. Mazzoni talks about this abnormal protein and explains when we can still effectively treat patients before it hits all the criteria for becoming multiple myeloma.
playlist_add
May 4, 2023
Turning Up the Heat: Benefits of Hyperthermia Therapy
Radiation Oncologist, Physician Scientist, and Founding Director of the Center for Hyperthermia at Cleveland Clinic, Jennifer Yu, MD, PhD, joins the Cancer Advances podcast to discuss hyperthermia therapy, which uses heat to destroy cancer cells and shrink tumors. Listen as Dr. Yu explains how this therapy works; and how it helps radiation and chemotherapy treatments become more effective for patients.
playlist_add
Apr 27, 2023
Identifying Risk Factors for Secondary Malignancy in Breast Cancer Survivors
The Cancer Advances podcast is joined by Abhay Singh, MD, MPH, a physician with the Department of Hematology and Medical Oncology at Cleveland Clinic to talk about his study, which aimed to identify risk factors for secondary malignancy in breast cancer survivors. This study was presented at the American Society of Hematology (ASH) 2022 annual meeting. Listen as Dr. Singh explains how he explored the different risk factors, such as G-CSF exposure, how the CHIP Clinic might be able to monitor patients, and the long-term goal to figure out which therapies patients should try to avoid.
playlist_add
Apr 20, 2023
Novel Therapeutics Clinic
Alex A. Adjei, MD, PhD, Chair of Cleveland Clinic Taussig Cancer Institute, joins the Cancer Advances podcast to discuss the new Novel Therapeutics Clinic. Listen as Dr. Adjei shares the importance of novel cancer therapetuics, how the clinic is structured, and his hopes of having multiple treatment options for every cancer.
playlist_add
Apr 13, 2023
Retinoblastoma
Arun D. Singh, MD, Director of Ophthalmic Oncology at Cleveland Clinic Cole Eye Institute, and Stacey Zahler, DO, a pediatric hematologist-oncologist at Cleveland Clinic Children's join the Cancer Advances podcast to discuss retinoblastoma. Listen as they discuss this unique children's eye cancer, the treatment options available, and the genetic counseling we have at Cleveland Clinic.
playlist_add
Apr 6, 2023
New ASCO Guidelines for Recurrent and Metastatic Head and Neck Cancers
Emrullah Yilmaz, MD, PhD, an oncologist at Cleveland Clinic Taussig Cancer Institute specializing in head and neck cancers, joins the Cancer Advances podcast to discuss new ASCO guidelines for recurrent and metastatic head and neck cancers. Listen as Dr. Yilmaz explains how the guidelines focus on biomarkers, tumor mutation burdens, and how they will impact patient care.
playlist_add
Mar 30, 2023
Insights into the MOMENTUM Trial
Aaron Gerds, MD, MS, a hematologist in Cleveland Clinic Cancer Center’s Leukemia and Myeloid Disorders Program and Deputy Director for Clinical Research at the Taussig Cancer Institute joins the Cancer Advances podcast to talk about the MOMENTUM trial that was presented at the American Society of Hematology (ASH) 2022 annual meeting. Listen as Dr. Gerds discusses myelofibrosis, the differences between the trial results from 24 to 48 weeks, and the exciting new approaches that are coming to the field.
playlist_add
Mar 23, 2023
Benefits of Complete Mesocolic Excision (CME) for Colon Cancer Patients
Hermann Kessler, MD, PhD, a senior colorectal surgeon in the Department of Colorectal Surgery, joins the Cancer Advances podcast to talk about the benefits of a complete mesocolic excision (CME) for patients with colon cancer. Listen as Dr. Kessler talks about improving survival and local recurrence rates, the importance of screening programs, and incorporating different modalities into surgery.
playlist_add
Mar 16, 2023
Mental Health of Children and Teens with Cancer
The Cancer Advances podcast is joined by Kate Eshleman, PsyD, a pediatric psychologist in the Center for Pediatric Behavioral Health at Cleveland Clinic Children's to talk about the mental health of children and teenagers with cancer. Listen as Dr. Eshleman discusses the Cleveland Clinic Children's survivorship program, what medical professionals should watch out for, and how to assist patient families.
playlist_add
Mar 9, 2023
Neuroendocrine Tumors
Chair of the Department of Gastroenterology, Hepatology, and Nutrition, Michelle Kang Kim, MD, PhD, joins the Cancer Advances podcast to discuss neuroendocrine tumors. Listen as Dr. Kim talks about creating a database of biomarker studies, the use of DOTATATE PET CT imaging, and the collaborative, multi-disciplinary approach taken at Cleveland Clinic to treat neuroendocrine tumors.
playlist_add
Mar 2, 2023
Using Artificial Intelligence to Diagnose Kidney Cancer
Christopher Weight, MD, Center Director of Urologic Oncology at Cleveland Clinic joins the Cancer Advances podcast to discuss using artificial intelligence to diagnose kidney cancer. Listen as Dr. Weight explains the progress we have made with imaging-generated software and a fully automated equivalent nephrometry score.
playlist_add
Feb 23, 2023
Managing the Differences between Invasive Lobular Breast Cancer and Invasive Ductal Breast Cancer
Breast Medical Oncologist at Cleveland Clinic Taussig Cancer Institute, Megan Kruse, MD, joins the Cancer Advances podcast to discuss the differences in the clinical management of invasive lobular breast cancer (ILC) and invasive ductal breast cancer (IDC). Listen as Dr. Kruse discusses the challenges of diagnosing, re-evaluating treatment options, and using genomic data to see different trends for lobular and ductal breast cancer.
playlist_add
Feb 16, 2023
Bariatric Surgery Substantially Lowers Risk of Obesity-Related Cancers
Ali Aminian, MD, Director of Cleveland Clinic's Bariatric and Metabolic Institute, joins the Cancer Advances podcast to talk about his study on how bariatric surgery can significantly lower a patient's risk of developing obesity-related cancers. Listen as Dr. Aminian explains how the study saw that with significant weight loss, the risk was reversible across race, sex, and age of the patients.
playlist_add
Feb 9, 2023
Radiation Oncology-Biology Integration Network (ROBIN)
Director of the Center for Immunotherapy and Precision Immuno-Oncology at Cleveland Clinic, Timothy Chan, MD, PhD, joins the Cancer Advances podcast to discuss the Radiation Oncology-Biology Integration Network (ROBIN). Listen as Dr. Chan talks about this new network of centers, the concentration on multi-modality therapies, and the trials that were funded as part of the center.
playlist_add
Feb 2, 2023
Predicting Survival using Genomic Adjusted Radiation Dose
Jacob Scott, MD, DPhil, radiation oncologist, associate professor, and staff physician-scientist at Cleveland Clinic, joins the Cancer Advances podcast to talk about the research he presented at the American Society of Radiation Oncology (ASTRO) 2022 Annual Meeting. Listen as Dr. Scott discusses preliminary results from a recent Cleveland Clinic study about using GARD to predict overall survival in patients with HPV positive oropharyngeal squamous cell carcinoma treated with radiotherapy.
playlist_add
Jan 26, 2023
POSITIVE Trial: Stopping Hormone Therapy for Pregnancy in Breast Cancer Patients
Stopping hormone therapy treatment to attempt pregnancy may be an option for hormone-receptor-positive breast cancer patients. Halle Moore, MD, Director of Breast Medical Oncology and Co-Director of the Comprehensive Breast Cancer Program joins the Cancer Advances podcast to discuss her research and encouraging findings of the POSITIVE trial that was presented at the San Antonio Breast Cancer Symposium (SABCS) 2022 annual meeting.
playlist_add
Jan 19, 2023
Optimizing CAR T-Cell and Stem Cell Transplants
The Director of the Blood and Marrow Transplant Program, Craig Sauter, MD, joins the Cancer Advances podcast to discuss optimizing treatments with CAR T-cell and stem cell transplants. Listen as Dr. Sauter talks about his goals to continue expanding the cellular therapy research team and to improve outcomes for transplant patients.
playlist_add
Jan 12, 2023
Center for Prevention of Cervical Cancer
Sharon Sutherland, MD, Director of the Center for Prevention of Cervical Cancer joins the Cancer Advances podcast to talk about the new center created to help prevent cervical cancer. Listen as Dr. Sutherland highlights the goals of the center, and the collaboration with pathology, primary care physicians, and gynecologic oncologists.
playlist_add
Jan 5, 2023
Advances in Pediatric Neuroblastoma Care
Stacey Zahler, DO, a pediatric hematologist-oncologist at Cleveland Clinic Children's, joins the Cancer Advances podcast to talk about the advances in neuroblastoma care for pediatric patients. Listen as Dr. Zahler talks about current treatment options, creating a metaiodobenzylguanidine (MIBG) therapy center at Cleveland Clinic, and studying difluoromethylornithine (DFMO) against cancer cells.
playlist_add
Dec 15, 2022
Psycho-Oncology Support
The emotional, psychological, and mental challenges of living with cancer are significant. In this Cancer Advances Podcast, Kaleena Chilcote, MD, Director of Psycho-Oncology at Taussig Cancer Institute talks about mental healthcare in patients who have cancer. Listen as Dr. Chilcote talks about cancer patients' mental health struggles from the beginning of their journey through survivorship and highlights how oncologists can collaborate with psychiatrists to help cancer patients with their quality of life.
playlist_add
Dec 8, 2022
New Leader’s Vision for Cleveland Clinic Cancer Center
Alex A. Adjei, MD, PhD, the new Chair of Cleveland Clinic Taussig Cancer Institute, joins the Cancer Advances podcast to share his vision for Cleveland Clinic Cancer Center. Listen as Dr. Adjei shares his background, goals, and his vision to integrate clinical trials as first line therapy in patient care.
playlist_add
Dec 1, 2022
Surgical Insights into Thyroid Cancer
Surgical Director of the Cleveland Clinic Thyroid Center, Joyce Shin, MD, joins the Cancer Advances podcast to provide surgical insights on thyroid cancer. Listen as Dr. Shin discusses the benefits of multidisciplinary care, molecular profiling, and using a fine needle aspiration for thyroid nodules.
playlist_add
Nov 17, 2022
Pancreatic Cancer Surgery Improvements
R. Matthew Walsh, MD, Department Chair of General Surgery at Cleveland Clinic, joins the Cancer Advances podcast to talk about surgical options for pancreatic cancer. Listen as Dr. Walsh discusses the Whipple procedure, minimally invasive approaches, robotics improvements and pre-habilitation.
playlist_add
Nov 10, 2022
FDA Approved: Lutetium-PSMA for Metastatic Prostate Cancer
Christopher Wee, MD, a medical oncologist from the Genitourinary Medical Oncology Program at Taussig Cancer Institute joins the Cancer Advances podcast to talk about therapies for metastatic prostate cancer. Listen as Dr. Wee discusses Lutetium-PSMA and the clinical trials that showed patients had better response rates and fewer toxicities when they got lutetium on top of their care.
playlist_add
Nov 3, 2022
Surgical Insight: Minimally Invasive Esophagectomy
Cleveland Clinic Akron General oncologic surgeon, Anthony Visioni, MD, joins the Cancer Advances podcast to discuss minimally invasive esophagectomies. Listen as Dr. Visioni talks about esophageal cancers and highlights how the team selects the appropriate surgical approach for these patients.
playlist_add
Oct 27, 2022
Retroperitoneal Lymph Node Dissection: A Robot Assisted Treatment for Testicular Cancer
Christopher Weight, MD, Center Director of Urologic Oncology at Cleveland Clinic joins the Cancer Advances podcast to discuss robot assisted retroperitoneal lymph node dissection (RPLND) for the treatment of testicular cancer. Listen as Dr. Weight explains how this robotic surgery allows shorter hospital stays, quicker recovery time, and a lower rate of chylous ascites.
playlist_add
Oct 20, 2022
Insights into the MAIN-CAV Trial for Patients with Urothelial Cancer
Shilpa Gupta, MD, director of genitourinary medical oncology at Taussig Cancer Institute and co-leader of the genitourinary oncology program at Cleveland Clinic Cancer Center joins the Cancer Advances podcast to discuss her research that was presented at the American Society of Clinical Oncology (ASCO) 2022 annual meeting. Listen as Dr. Gupta gives us insights into the MAIN-CAV trial and platinum-ineligibility in metastatic urothelial cancer.
playlist_add
Oct 13, 2022
Young Women’s Clinic for Breast Cancer Patients
Medical Director of the Breast Center at Cleveland Clinic Fairview Hospital, Stephanie Valente, DO, joins the Cancer Advances podcast to discuss the Young Women's Clinic. Listen as Dr. Valente discusses the program, survivorship, and the factors physicians address for younger breast cancer patients.
playlist_add
Oct 6, 2022
Breast Cancer Recurrence
Chirag Shah, MD, co-director of Breast Radiation and Clinical Research in the Department of Radiation Oncology at Cleveland Clinic, joins the Cancer Advances podcast to discuss breast cancer recurrence. Listen as Dr. Shah discusses his research that was presented at the American Society of Clinical Oncology (ASCO) 2022 annual meeting to help patients that are at risk of recurrence.
playlist_add
Sep 29, 2022
Advancements in Prostatectomy: Single-Port Transvesical Robot Assisted Radical Prostatectomy
Director of the Center of Advanced Robotic and Image-Guided Surgery at Cleveland Clinic's Glickman Urological & Kidney Institute, Jihad Kaouk, MD joins the Cancer Advances podcast to discuss single-port transvesical robot assisted radical prostatectomy. Listen as Dr. Kaouk explains advancements that have been made to prostatectomies and how we are continuing to innovate.
playlist_add
Sep 22, 2022
Nomograms
Michael Kattan, PhD, Chair of the Department of Quantitative Health Sciences at Cleveland Clinic, and Rahul Tendulkar, MD, radiation oncologist at Cleveland Clinic Cancer Center join the Cancer Advances podcast to discuss nomograms, a calculation tool designed to allow clinicians to evaluate the collective risk of multiple factors at once. Listen as they discuss the creation of nomograms and how they can be helpful to evaluate treatment options for cancer patients.
playlist_add
Sep 15, 2022
CAR T-Cell Therapy and Immunotherapy in Pediatric Cancers
Seth Rotz, MD, pediatric hematologist-oncologist and Director of the Childhood Cancer Survivorship Program at Cleveland Clinic Children's, joins the Cancer Advances podcast to talk about CAR T-cell therapies and immunotherapy in pediatric patients. Listen as Dr. Rotz explains the long-term survivorship factors to consider when using these therapies and the exciting studies that are being developed for this type of treatment.
playlist_add
Sep 8, 2022
PSMA PET Scan: Improving Treatment for Patients with Prostate Cancer
Rahul Tendulkar, MD, radiation oncologist at Cleveland Clinic Cancer Center, joins the Cancer Advances podcast to talk about the PSMA PET scan for patients with prostate cancer. Listen as Dr. Tendulkar explains the benefits and how the scan is changing the way we think about and treat prostate cancer.
playlist_add
Sep 1, 2022
Prostate Cancer Survivorship
Petar Bajic, MD, a urologist in the Center for Men's Health at Cleveland Clinic's Glickman Urological and Kidney Institute, joins the Cancer Advances podcast to discuss Prostate Cancer Survivorship. Listen as Dr. Bajic discusses the difficulties patients face following prostate cancer treatment and the options available to help with urinary and sexual-health issues. He also discusses the importance of a multidisciplinary collaboration between oncologists, general practitioners, and mental health specialists.
playlist_add
Aug 25, 2022
Future of CAR T-Cell Therapy
J. Joseph Melenhorst, PhD, Director of the Cell Therapy and Immuno-Engineering program and Vice Chair of the Center for Immunotherapy and Precision Immuno-Oncology, joins the Cancer Advances podcast to talk about the future of CAR T-Cell Therapy. Listen as Dr. Melenhorst discusses the progress being made, barriers to overcome, and and how we can improve cellular therapy to treat even more types of cancer.
playlist_add
Aug 18, 2022
VeloSano: Cancer Research Fundraising
Nicole Peters, Executive Director of VeloSano in the Cleveland Clinic Philanthropy Institute, joins the Cancer Advances podcast to talk about VeloSano, a year-round fundraising initiative that supports lifesaving cancer research at Cleveland Clinic. Listen as Nicole discusses how VeloSano was started, our flagship Bike to Cure weekend, and highlights of how 100% of the funds go toward advancing cancer research.
playlist_add
Aug 11, 2022
Aggressive Lymphoma Early Alert Process
Cleveland Clinic hematology oncologist, Allison Winter, MD, joins the Cancer Advances podcast to discuss the early alert process for aggressive lymphoma. Listen as Dr. Winter covers the importance of time to treat for this disease and what Cleveland Clinic is doing to help see patients sooner.
playlist_add
Aug 4, 2022
KRYSTAL-1 Lung Cancer Trial
Director of the Lung Cancer Medical Oncology Program at Cleveland Clinic Taussig Cancer Institute, Nathan A. Pennell, MD, PhD joins the Cancer Advances podcast to discuss the KRYSTAL-1 trial, a new treatment option for patients with advanced non-small-cell lung cancer with KRASG12C mutation. Listen as Dr. Pennell explains the trial and findings that were presented at the American Society of Clinical Oncology (ASCO) 2022 annual meeting.
playlist_add
Jul 28, 2022
Pediatric Hematology/Oncology Mobility Program
Julie Nowicki PT, DPT, a physical therapist at Cleveland Clinic's Children’s, joins the 100th episode of the Cancer Advances podcast to talk about the Pediatric Hematology/Oncology Mobility Program. Listen as Julie discusses the program and the benefit of physical therapy for children undergoing cancer treatments.
playlist_add
Jul 21, 2022
A Retrospective on Anterolateral Thigh Fascia Lata Rescue Flap for Osteoradionecrosis
Michael Fritz, MD, Section Head of Facial Plastic and Microvascular Surgery in Cleveland Clinic's Head & Neck Institute, joins the Cancer Advances podcast to discuss anterolateral thigh fascia lata rescue flap for osteoradionecrosis. Listen as Dr. Fritz highlights how the operation allows patients to get back to their everyday lives sooner.
playlist_add
Jul 14, 2022
Pediatric Cancer Predispositions
Harry (Adrian) Lesmana, MD, pediatric hematologist/oncologist and medical geneticist at Cleveland Clinic Children's joins the Cancer Advances podcast to talk about pediatric cancer predispositions. Listen as Dr. Lesmana describes gene predispositions for solid tumors vs hematologic cancers as well as the study he is working on to increase the ability to identify these genes through genomic sequencing.
playlist_add
Jul 7, 2022
Repairing Cancer Cells Rather than Destroying Them
Yogen Saunthararajah, MD, hematologist/oncologist at Cleveland Clinic Cancer Center, joins the Cancer Advances podcast to discuss his study on repairing cancer cells. Listen as Dr. Saunthararajah discusses how he is trying to change the mindset from search and destroy to replenishment and repair.
playlist_add
Jun 30, 2022
The Rise in Pediatric Thyroid Cancer Cases
Rachel Georgopoulos, MD, pediatric otolaryngologist and Director of the Thyroid Head and Neck Oncology and Pediatric Endocrine (Thyroid HOPE) Center, and Stefanie Thomas, MD, hematologist/oncologist at Cleveland Clinic Children’s join the Cancer Advances podcast to discuss the rise in pediatric thyroid cancer cases. Listen as they discuss the possible factors causing the increase in cases and the multidisciplinary care given at the Thyroid HOPE Center.
playlist_add
Jun 23, 2022
Focused Ultrasound to Open the Blood-Brain Barrier
Neurologist/Neuro-oncologist in Cleveland Clinic’s Rose Ella Burkhardt Brain Tumor & Neuro-Oncology Center, Glen Stevens, DO, PhD, joins the Cancer Advances podcast to talk about the treatment of recurrent glioblastoma. Listen as Dr. Stevens discusses how a study mixing old principles with a new technique may disrupt the BBB, allowing chemotherapy to reach tumor cells.
playlist_add
Jun 16, 2022
Optimizing Surgical Options for patients with Bladder Cancer
Byron Lee, MD, PhD, a urologist in Cleveland Clinic's Glickman Urological and Kidney Institute joins the Cancer Advances podcast to discuss expanding surgical options for patients with bladder cancer. Listen as Dr. Lee compares robotic surgery verses open surgery and what we are doing to improve patient outcomes.
playlist_add
Jun 9, 2022
Creating a Guide: Salivary Tumors
Vice Chair of the Department of Hematology and Medical Oncology, and head and neck medical oncologist, Jessica Geiger, MD joins the Cancer Advances podcast to talk about formulating guidelines for salivary gland tumors. Listen as Dr. Geiger explains the six main clinical questions that the guidelines aims to answer.
playlist_add
Jun 2, 2022
Benefits of Virtual Second Opinions
Peter Rasmussen, MD, cerebral vascular surgeon and Chief Clinical Officer of Virtual Second Opinions by Cleveland Clinic, joins the Cancer Advances podcast to discuss the benefits of Virtual Second Opinions. Listen as Dr. Rasmussen talks about this service at Cleveland Clinic and our goal to give patients the best opinion on what they can do now and in the future.
playlist_add
May 26, 2022
Improving Outcomes for Patients with Metastatic Melanoma
Lucy Boyce Kennedy, MD, hematology and medical oncologist at Cleveland Clinic Cancer Center, joins the Cancer Advances podcast talk about improving outcomes for patients with metastatic melanoma. Listen as Dr. Kennedy explains how treatment for this disease has improved over the last 10+ years.
playlist_add
May 19, 2022
CAR T-Cell Therapy for Multiple Myeloma
Faiz Anwer, MD, hematology oncologist at Cleveland Clinic Cancer Center, joins the Cancer Advances podcast to discuss CAR T-cell therapy for Multiple Myeloma. Listen as Dr. Anwer discusses the trials aiming to move CAR T-cell therapy treatment to the forefront.
playlist_add
May 12, 2022
Discoveries in CAEL-101 Trial for Patients with AL Amyloidosis
Jason Valent, MD, Director of the Multiple Myeloma Program and Co-Director of the Amyloidosis Program at Cleveland Clinic Cancer Center, joins the Cancer Advances podcast to discuss the developments of the CAEL-101 trial for patients with AL amyloidosis. Listen as Dr. Valent talks about the discoveries and changes in treatment in each phase of the trial.
playlist_add
May 5, 2022
Looking Out for Rare Cancer: Uveal Melanoma
Arun Singh, MD, Director of Ophthalmic Oncology at Cleveland Clinic Cole Eye Institute, joins the Cancer Advances podcast to discuss uveal melanoma. Listen as Dr. Singh explains the symptoms to look out for, treatment, and new therapies in development for this rare eye cancer.
playlist_add
Apr 28, 2022
Transperineal Biopsy and Advancements in Screening for Prostate Cancer
Urologic oncologist in the Glickman Urological and Kidney Institute, Zeyad Schwen, MD joins the Cancer Advances podcast to discuss transperineal biopsy and advances in screening for prostate cancer. Listen as Dr. Schwen explains the benefits of the transperineal prostate biopsy technique and why with the use of better imaging, as well as reduced risks of infection, this technique is coming to the forefront.
playlist_add
Apr 21, 2022
Esophageal Cancer Program
Suneel Kamath, MD, hematologist/medical oncologist and Siva Raja, MD, PhD, Surgical Director of the Center for Esophageal Diseases joins the Cancer Advances podcast to discuss the Esophageal Cancer Program. Listen as Dr. Kamath and Dr. Raja discuss this multidisciplinary program and the significant advancements that have been made over the last several years including less invasive therapies to treat esophageal cancer.
playlist_add
Apr 14, 2022
Less-Intensive Therapies for Acute Myeloid Leukemia Tied to Higher Mortality Risks
Aaron Gerds, MD, MS, hematologist in Cleveland Clinic Cancer Center’s Leukemia & Myeloid Disorders Program joins the Cancer Advances podcast to talk about acute myeloid leukemia. Listen as Dr. Gerds discusses less intensive therapies for acute myeloid leukemia and their impact on mortality.
playlist_add
Apr 7, 2022
Vaccine Research for Head and Neck Cancers
Director of Head and Neck Research and surgical oncologist at Cleveland Clinic, Natalie Silver, MD, MS, joins the Cancer Advances podcast to talk about head and neck cancers and the treatment barriers we are trying to overcome. Listen as Dr. Silver explains how she is trying to bridge the gap between the clinical and translational research with her work on vaccines.
playlist_add
Mar 31, 2022
Modified Drug Regimen May Reduce Risks in Allogeneic Hematopoietic Cell Transplant Patients
Betty Hamilton, MD, Interim Director of the Blood and Marrow Transplant (BMT) Program at Cleveland Clinic joins the Cancer Advances podcast to discuss research and findings that were presented at the 2021 American Society of Hematology Annual Meeting (ASH). Listen as Dr. Hamilton discusses graft-versus-host disease and the study that evaluates a new regimen.
playlist_add
Mar 24, 2022
Gene Therapy in Sickle Cell Disease
Rabi Hanna, MD, Chair of the Department of Pediatric Hematology, Oncology and Blood and Marrow Transplantation at Cleveland Clinic Children's joins the Cancer Advances podcast to discuss the use of gene therapy in sickle cell disease. Listen as Dr. Hanna describes how the last several years have brought significant advancements in the field, expanding our understanding and treatment of sickle cell disease, including the possibility of curative gene therapy.
playlist_add
Mar 17, 2022
Functional Drug Screening and Genomic Profiling in Advanced Sarcoma
Program Director of Cleveland Clinic Florida's Sarcoma Program, Jorge Manrique-Succar, MD, joins the Cancer Advances podcast to discuss a feasibility study for drug sensitivity testing and genetic profiling in adults with advanced sarcomas. Listen as Dr. Manrique-Succar highlights how the results from the study will lay grounds for future testing and potentially guide future treatment options.
playlist_add
Mar 10, 2022
Lysosomal Storage Disease Program
Rabi Hanna, MD, Chair of the Department of Pediatric Hematology, Oncology and Blood and Marrow Transplantation at Cleveland Clinic Children's and Angelika Erwin, MD, PhD, Medical Geneticist at the Center for Personalized Genetic Healthcare at the Cleveland Clinic join the Cancer Advances podcast to discuss the lysosomal storage disease program (LSD). Listen as Dr. Hanna and Dr. Erwin discuss how the interdisciplinary team for children and adults with LSDs is dedicated to improving diagnosis, management and treatment of these disorders.
playlist_add
Mar 3, 2022
Treating Retroperitoneal Sarcoma
Nathan Mesko, MD, Center Director, Orthopaedic Oncology, and Co-Director of Sarcoma Care at Cleveland Clinic and Daniel Joyce, MBBCh, surgical oncologist, join the Cancer Advances podcast to discuss the treatment of retroperitoneal sarcomas. Listen as Dr. Mesko and Dr. Joyce highlight the value of having a multidisciplinary team to ensure the best outcomes for patients with retroperitoneal sarcoma.
playlist_add
Feb 24, 2022
Biomarkers Predict Outcomes of CAR T-Cell Therapy in Patients with Diffuse Large B-Cell Lymphoma
Brian Hill, MD, PhD, Director of the Lymphoid Malignancies Program joins the Cancer Advances podcast to discuss research and findings that were presented at the 2021 American Society of Hematology Annual Meeting (ASH). Listen as Dr. Hill discusses how CAR T-Cell therapy may be a lifesaving option for patients with relapsed or refractory disease.
playlist_add
Feb 17, 2022
Cancer Genomic Testing Capabilities
Director of the Center for Immunotherapy and Precision Immuno-Oncology at Cleveland Clinic, Timothy Chan, MD, PhD, joins the Cancer Advances podcast to discuss cancer genomic testing capabilities. Listen as Dr. Chan discusses how Cleveland Clinic offers an advanced genomic testing platform as the standard of care to patients with cancer. This expanded capability allows clinicians to identify genetic defects and connect patients with individualized, lifesaving therapies.
playlist_add
Feb 10, 2022
Advances in Aggressive Thyroid Cancer Treatment
Joseph Scharpf, MD, FACS, Director of Head and Neck Endocrine Surgery at the Cleveland Clinic Head and Neck Institute and Katherine Heiden, MD, an endocrine surgeon at the Cleveland Clinic Endocrinology and Metabolism Institute join the Cancer Advances podcast to discuss the latest advances in aggressive thyroid cancer treatment. Listen as Dr. Scharpf and Dr. Heiden discuss how their collaborative approach and new advancements are contributing to the future care of thyroid cancer.
playlist_add
Feb 3, 2022
Childhood Cancer Survivorship
Today, more children are surviving cancer than ever before. But now, increasing efforts are needed to detect and treat late effects as early as possible. Seth Rotz, MD, Director of the Childhood Cancer Survivorship Program at Cleveland Clinic Children’s joins the Cancer Advances podcast to discuss survivorship. Listen as Dr. Rotz highlights how Cleveland Clinic is helping ensure survivor success by identifying and managing late effects in survivors.
playlist_add
Jan 27, 2022
A Collaborative Solution to Lung Nodule Management
Lung nodules are one of the most common incidental findings seen on radiology exams. Director of the Lung Cancer Program and Lung Cancer Screening Program for the Respiratory Institute, Peter Mazzone, MD, MPH, joins the Cancer Advances podcast to discuss Cleveland Clinic's lung nodule management program. The new program was developed to track the management of these lung nodules throughout the enterprise while ensuring care path compliant management in accordance with the most updated guidelines.
playlist_add
Jan 20, 2022
New Cell Therapies May Hold Key to Treatment of Advanced and Rare Skin Cancers
Brian Gastman, MD, Surgical and Co-Director of Cleveland Clinic’s Melanoma and High-Risk Skin Cancer Program joins the Cancer Advances podcast to discuss Merkel cell carcinoma (MCC). Listen as Dr. Gastman discusses clinical trials exploring the use of immunotherapy with adoptive cell transfer for advanced melanoma and Merkel cell carcinoma.
playlist_add
Jan 13, 2022
Liquid Biopsy in Breast Cancer
Chief of Breast Surgery at Cleveland Clinic Cancer Center, Julie Lang, MD, joins the Cancer Advances podcast to discuss liquid biopsies in breast cancer. Listen as Dr. Lang discusses how liquid biopsies have been used in the past and how she's using them in a new study, funded in part by VeloSano. The study will use next-generation sequencing to detect circulating tumor DNA in the blood samples and to try to improve upon an existing assay based on biomarkers that may be secreted by different types of tumors, benign and malignant.
playlist_add
Jan 6, 2022
Patient and Family Support Services
At Cleveland Clinic, exceptional cancer care is complemented by services that address the emotional, psycho-social, and financial needs of our patients. Melanie Robbins-Ong, DO, palliative and supportive care specialist at Cleveland Clinic Cancer Center joins the Cancer Advances podcast to discuss the importance of patient and family support services. Listen as Dr. Robbins-Ong describes the different types of services we offer not only for our patients but also for their families and care partners.
playlist_add
Dec 23, 2021
POEMS: A Rare, Often Misdiagnosed and Disabling Condition if Not Properly Treated
Jack Khouri, MD, hematologist oncologist at Cleveland Clinic Cancer Center, who specializes in rare plasma cell disorders within the Rare Cancers and Blood Diseases program joins the Cancer Advances podcast to discuss POEMS (i.e., polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes). Listen as Dr. Khouri talks about how the early recognition and diagnosis of POEMS is key to effective management.
playlist_add
Dec 16, 2021
Biosignature Predicts Benefit of Adjuvant Radiotherapy in Patients With DCIS
Results from a multi-institutional study led by a Cleveland Clinic researcher, DCSionRT®, a biosignature based on multiple biomarkers, may hold the key to solving the treatment of ductal carcinoma in situ (DCIS). Chirag Shah, MD, coinvestigator, and director of Breast Radiation Oncology at Cleveland Clinic joins the Cancer Advances podcast to explain the study and findings that were presented at the American Society for Radiation Oncology annual meeting (ASTRO).
playlist_add
Dec 9, 2021
The Latest Advances in Lymphovenous Bypass Surgery
Medical Director of the Breast Center at Cleveland Clinic Fairview Hospital, Stephanie Valente, DO, joins the Cancer Advances podcast to discuss lymphovenous bypass surgery and its connection to breast cancer. Listen as Dr. Valente highlights the procedure and advances being made in breast surgery at Cleveland Clinic.
playlist_add
Dec 2, 2021
Cleveland Clinic's Center for Young-Onset Colorectal Cancer
Suneel Kamath, MD, hematologist and medical oncologist at Cleveland Clinic Cancer Center, joins the Cancer Advances podcast for the second time to discuss our new Center for Young-Onset Colorectal Cancer. Listen as Dr. Kamath discusses how the center was established, and how it will allow us to take a comprehensive and multidisciplinary approach to research, diagnosis, and treatment of young-onset colorectal cancer.
playlist_add
Nov 18, 2021
Funding Disparities Affecting Cancers with High Mortality Rates
Hematologist and medical oncologist at Cleveland Clinic Cancer Center, Suneel Kamath, MD, joins the Cancer Advances podcast to discuss his research on funding disparities. Many cancers with higher mortality rates and high incidence are underfunded, including colorectal, lung, hepatobiliary and uterine cancers. Listen as Dr. Kamath discusses his research from the American Society of Clinical Oncology (ASCO) 2021 annual meeting, highlighting how critical funding is for advancing cancer research.
playlist_add
Nov 11, 2021
New Developments in Cell Therapy
Paolo Caimi, MD, Associate BMT Director for Cell Therapy at Cleveland Clinic Cancer Center, joins the Cancer Advances podcast to discuss new developments and clinical trials in cell therapy. Listen as Dr. Caimi discusses how the field is changing, along with the primary advantages and disadvantages of using cellular therapy compared to chemotherapy.
playlist_add
Nov 4, 2021
Cardio-Oncology for Pediatric and Adult Cancer Patients
Pediatric heart failure and transplant cardiologist at Cleveland Clinic Children's, Shahnawaz Amdani, MD, joins the Cancer Advances podcast to discuss cardio-oncology for both pediatric and adult cancer patients who are undergoing chemotherapy or have completed their chemotherapy and are now long-term survivors. Listen as Dr. Amdani highlights when and how cardiac toxicity develops, preventative therapies and how the field has evolved.
playlist_add
Oct 28, 2021
Triple-Negative Breast Cancer Prevention Vaccine
Cleveland Clinic recently opened a clinical trial to determine the maximum tolerated dose of a vaccine in patients with non-metastatic triple-negative breast cancer (TNBC). The breast cancer vaccine was invented and developed by Cleveland Clinic immunologist Vincent Tuohy, PhD, and his research team. Cleveland Clinic medical oncologist and principal investigator, G. Thomas Budd, MD, joins the Cancer Advances podcast to discuss the trial origins and what we are looking to accomplish.
playlist_add
Oct 21, 2021
Our Approach to Community Outreach
Miriam Hernandez, Program Manager in Community Outreach at Cleveland Clinic Cancer Center, joins the Cancer Advances podcast to talk about our approach to community outreach and how we’re helping to educate and provide cancer screenings for the underserved population. Listen as Miriam highlights how the community outreach program initially started, what initiatives they are actively doing within the community, and how they are making a difference.
playlist_add
Oct 14, 2021
Innovations in Pulmonary Stents for Cancer Patients
Thomas Gildea, MD, interventional pulmonologist and Section Head of Bronchology in Cleveland Clinic's Respiratory Institute joins the Cancer Advances podcast to discuss the use of pulmonary lung stents for cancer patients. Listen as Dr. Gildea discusses the different ways his team is able to customize lung stents for each patient, including the new FDA-approved 3D-printed stent. Learn how he is continuing to move this field forward and improve our ability to take care of patients before and after the placement of lung stents.
playlist_add
Oct 7, 2021
The Latest in Pancreatic Surgery
Cleveland Clinic Akron General surgeon, Terence Jackson, MD, joins the Cancer Advances podcast to talk about the latest advances in pancreatic cancer surgery. Listen as Dr. Jackson covers some of the different techniques, which seem to be the most effective, and what types of patients make the best candidates.
playlist_add
Sep 30, 2021
Stereotactic Radiosurgery in the Treatment Landscape for Brain Metastases
Gene Barnett, MD, MBA, neurosurgeon and Director of the Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center joins the Cancer Advances podcast to discuss the standard of care for brain metastases. Listen as Dr. Barnett discusses how the traditional surgical approaches for treating patients with brain metastases have evolved and how we are using stereotactic radiosurgery to deliver superior outcomes.
playlist_add
Sep 23, 2021
Brian Bolwell, MD, His Ongoing Journey in Leadership
Chair of Physician Leadership and Development within the Mandel Global Leadership and Learning Institute at Cleveland Clinic, Brian Bolwell, MD, joins the Cancer Advances podcast to reflect on his time as leader of Cleveland Clinic Cancer Center and his ongoing journey in leadership. Listen as Dr. Bolwell shares his story on how he became a leader, lessons learned along the way and advice for upcoming leaders in healthcare.
playlist_add
Sep 16, 2021
National Ewing Sarcoma Tumor Board Connects Experts
Physicians treating patients with Ewing sarcoma get a chance to discuss challenging cases with experts from Cleveland Clinic, Cleveland Clinic Children's and other leading cancer centers throughout the country in a new National Ewing Sarcoma Tumor Board, led by Matteo Trucco, MD, a pediatric hematologist oncologist at Cleveland Clinic Children’s. Dr. Trucco joins the Cancer Advances podcast to talk about how the tumor board started, what to expect and how you can get involved.
playlist_add
Sep 9, 2021
The Latest Trends in Melanoma Care
Cleveland Clinic Akron General oncologic surgeon, Anthony Visioni, MD, joins the Cancer Advances podcast to discuss the latest trends in melanoma care. Listen as Dr. Visioni highlights the importance of a multidisciplinary team and how recent clinical trials have caused a paradigm shift in melanoma care.
playlist_add
Sep 2, 2021
Focal One Therapy | HIFU
Christopher Weight, MD, Center Director of Urologic Oncology at Cleveland Clinic joins the Cancer Advances podcast to discuss how high-intensity focused ultrasound (HIFU), a type of focal therapy for treating localized prostate cancer, is emerging as an alternative to more traditional treatments, such as surgery and radiation for select patients. Listen as Dr. Weight explains how improved HIFU technology, coupled with appropriate patient selection, is enabling us to provide this modality as an outpatient procedure.
playlist_add
Aug 20, 2021
CAR T-cell Therapy Management
Betty Hamilton, MD, Associate Director of the Blood and Marrow Transplant (BMT) Program at Cleveland Clinic joins the Cancer Advances podcast to talk about managing chimeric antigen receptor (CAR) T-cell therapy and other novel cellular therapies within different cancer programs to support participation in and expansion of new clinical trials.
playlist_add
Aug 19, 2021
Liver Tumor Ablation
Cleveland Clinic is the first hospital in the world to use an FDA-approved ablation technology that can destroy large liver tumors. Director of Cleveland Clinic's Surgical Liver Ablation Program, Eren Berber, MD, joins the Cancer Advances podcast to discuss how the latest technology allows us to treat larger liver tumors more confidently.
playlist_add
Aug 12, 2021
Newest Techniques in Oncoplasty
Oncoplastic surgery, which combines lumpectomy with reconstructive surgery, is an option for an increasing number of breast cancer patients. Vice-Chairman of the Department of Plastic Surgery at Cleveland Clinic, Risal Djohan, MD, joins the Cancer Advances podcast to discuss the latest techniques in oncoplastic surgery and which patients make ideal candidates.
playlist_add
Aug 5, 2021
Cancer Affiliate Program
Director of Strategic Growth for Cleveland Clinic Cancer Center, Shannon Faulhaber, joins the Cancer Advances podcast to talk about the Cancer Affiliate program. Listen as Shannon highlights what it means to be an affiliate of Cleveland Clinic Cancer Center and how your patients and organization can benefit.
playlist_add
Jul 29, 2021
SBRT for Oligometastic Disease
Ehsan Balagamwala, MD, radiation oncologist at Cleveland Clinic Cancer Center, joins the Cancer Advances podcast to talk about stereotactic body radiation therapy (SBRT) for oligometastatic disease. Listen as Dr. Balagmwala highlights how we are pushing the boundaries with SBRT clinical trials, the benefits, and how you can refer a patient.
playlist_add
Jul 22, 2021
Onco-Nephrology Program
Onco-nephrology is a nascent field. Nephrologist Roman Shingarev, MD, joins the Cancer Advances podcast to discuss Cleveland Clinic's new onco-nephrology program. Listen as Dr. Shingarev talks about the patients he treats, the program he is building, and what’s ahead in this growing field.
playlist_add
Jul 15, 2021
Treatment for Peritoneal Malignancies
Michael Valente, DO, FACS, FASCRS, Associate Professor of Surgery and Program Director of Cleveland Clinic's Colorectal Surgery Residency Program, joins the Cancer Advances podcast to highlight some of the different strategies for treating peritoneal malignancies, including HIPEC. Listen to learn how treatments have evolved and which patients might be good candidates.
playlist_add
Jul 8, 2021
The Longstanding Controversy between Partial Nephrectomy vs. Radical Nephrectomy
Steven Campbell, MD, PhD, urologic surgeon, and member of the Section of Urologic Oncology in Cleveland Clinic’s Glickman Urological and Kidney Institute, joins the Cancer Advances podcast to discuss the longstanding controversy between partial nephrectomy vs. radical nephrectomy. Listen as Dr. Campbell highlights the possible advantages and disadvantages of each approach and how to know which is best for your patient.
playlist_add
Jul 1, 2021
Advances in Laparoscopic Liver Surgery for Liver Cancer
Director of Laparoscopic Liver Surgery, Choon Hyuck David Kwon, MD, PhD, joins the Cancer Advances podcast to discuss some of the recent advances in laparoscopic liver surgery for liver cancer. Listen as Dr. Kwon highlights new approaches and how having a well-established tumor board and multidisciplinary team can yield better results.
playlist_add
Jun 24, 2021
Current Advances in Breast Reconstruction
Cleveland Clinic Akron General plastic surgeon, Sarah Bishop, MD, joins the Cancer Advances podcast to talk about some of the recent advances in breast cancer reconstruction. Listen as Dr. Bishop covers some of the different reconstructive techniques, which patients are the best candidates and when is the best timing for patients to undergo breast reconstruction.
playlist_add
Jun 17, 2021
Salvage Operations Related to Post Treatment Complications
Michael Fritz, MD, the Director of the Section of Facial Plastic and Microvascular Surgery, joins the Cancer Advances podcast to discuss salvage operations to improve complications or dysfunction related to prior cancer treatment. Listen as Dr. Fritz highlights different techniques used for salvage surgery and how they have evolved over time.
playlist_add
Jun 10, 2021
Challenges and Opportunities in Pediatric Sarcoma Care
Pediatric Hematologist-Oncologist at Cleveland Clinic Children's, Peter Anderson, MD, joins the Cancer Advances podcast to talk about the challenges and areas of opportunity in pediatric sarcoma care. Listen as Dr. Anderson covers the importance of multidisciplinary care when managing pediatric sarcoma patients and how virtual visits have become more important than ever.
playlist_add
Jun 3, 2021
Novel Strategies for Facial Reconstruction After Cancer Extirpation
Chair of the Head and Neck Institute at Cleveland Clinic, Patrick Byrne, MD, MBA, joins the Cancer Advances podcast to discuss novel strategies for facial reconstruction after cancer extirpation. He touches on how facial reconstruction techniques have evolved over the past decade resulting in lower complication rates and how the multidisciplinary team works together for better outcomes.
playlist_add
May 27, 2021
Bone Marrow Failure and Cytopenias Program
Jaroslaw Maciejewski, MD, PhD, Chair of the Department of Translational Hematology and Oncology Research and Co-Director of the Bone Marrow Failure and Cytopenias Program, joins the Cancer Advances podcast to discuss these rare conditions. Listen as Dr. Maciejewski highlights how the Bone Marrow Failure and Cytopenias program initially started, what patients might benefit and how physicians can make referrals.
playlist_add
May 20, 2021
Cleveland Clinic’s Endoluminal Surgery Center and Lesions in the Lower Tract
Emre Gorgun, MD, colorectal surgeon and co-director of Cleveland Clinics Endoluminal Surgery Center, joins the Cancer Advances podcast to discuss the center and management of lesions in the lower GI tract. Listen as Dr. Gorgun explains our approach to resecting lower GI polyps and how this allows patients to avoid surgery, keep their native organs and have an improved quality of life.
playlist_add
May 13, 2021
Cleveland Clinic's Endoluminal Surgery Center and Lesions in the Upper Tract
Gastroenterologist, advanced endoscopist, and co-director of Cleveland Clinic's Endoluminal Surgery Center, Amit Bhatt, MD, joins the Cancer Advances podcast to discuss the center and management of lesions in the upper GI tract. Listen as Dr. Bhatt gives insight on why the center was initially created, how it has evolved and its benefits for patients.
playlist_add
May 6, 2021
Leading the Way | Innovations in Prostate Cancer Care
Eric Klein, MD, Chairman of Cleveland Clinic’s Glickman Urological & Kidney Institute joins the Cancer Advances podcast to discuss how we are leading the way in prostate cancer care. Listen as Dr. Klein highlights the four areas of innovation that are transforming the treatment of prostate cancer and providing individualized, high-quality care for our patients.
playlist_add
Apr 29, 2021
Early Phase Clinical Trial Program - Cleveland Clinic's Children’s Cancer Innovative Therapy Program
In order to bring novel, more effective therapies to the youngest patients, Cleveland Clinic launched a new, early phase clinical trial program called Cleveland Clinic Children’s Cancer Innovative Therapy Program, led by Matteo Trucco, MD, a pediatric hematologist oncologist at Cleveland Clinic Children’s. Dr. Trucco joins the Cancer Advances podcast to talk about the program and how it's bringing novel therapies to patients with pediatric cancers.
playlist_add
Apr 22, 2021
Virally Related Head and Neck Cancers: The Quiet Epidemic
Eric Lamarre, MD, Interim Section Head of Head and Neck Surgery and Oncology with Cleveland Clinic’s Head & Neck Institute, joins the Cancer Advances podcast to talk about HPV-related head and neck cancers. Listen as Dr. Lamarre discusses the shift in demographics for patients with virally related head and neck cancers and the evolution of treatment options.
playlist_add
Apr 15, 2021
Fertility Preservation Program for Male Cancer Patients
Sarah Vij, MD, Director of the Center for Male Fertility at Cleveland Clinic, joins the Cancer Advances podcast to discuss Cleveland Clinic's Fertility Preservation Program for Male Cancer Patients. Listen as Dr. Vij discusses the different fertility-sparing techniques used for both pre-pubertal and post-pubertal male cancer patients.
playlist_add
Apr 8, 2021
Fertility Preservation Program for Female Cancer Patients
Chair of Subspecialty Care for Women's Health at Cleveland Clinic, Laura Detti, MD, joins the Cancer Advances podcast to discuss Cleveland Clinic's Fertility Preservation Program for Female Cancer Patients. Listen as Dr. Detti highlights the different fertility-sparing techniques used for female cancer patients and the many factors that determine the best option for each patient.
playlist_add
Apr 1, 2021
Adolescent and Young Adult (AYA) Cancer Program
Compared to younger children, cancer rates are higher in adolescents and young adults (AYA). However, AYA's are less likely to receive a prompt diagnosis or be enrolled in clinical trials for innovative treatment. Cleveland Clinic Children's pediatric hematologist oncologist, Stefanie Thomas, MD, joins the Cancer Advances podcast to discuss Cleveland Clinic Children's Adolescent and Young Adult cancer program. Listen as Dr. Thomas covers why the program was developed and how it is impacting our patients.
playlist_add
Mar 25, 2021
The Latest in Lymphedema
Graham Schwarz, MD, FACS, Director of the Cleveland Clinic Microsurgery and Breast Reconstruction Fellowship and Co-Director of the Multidisciplinary Center for Lymphedema Care, joins the Cancer Advances podcast to talk about the latest in lymphedema. Listen as Dr. Schwarz discusses the Multidisciplinary Lymphedema Center and how patients can benefit, along with the big impact microsurgery and supermicrosurgery have made in lymphedema treatment.
playlist_add
Mar 18, 2021
Non-Operative Organ Sparing Approach for Rectal Cancer
Emre Gorgun, MD, colorectal surgeon and co-director of Cleveland Clinic's Colorectal Cancer Program, joins the Cancer Advances podcast to discuss our non-operative organ sparing approach for rectal cancer. Listen as Dr. Gorgun explains how this new care path allows about a third of stage II and III locally advanced rectal cancer patients avoid surgery.
playlist_add
Mar 11, 2021
4th Angel Mentoring Program
Carrie Emch, Program Coordinator for the Cleveland Clinic 4th Angel Mentoring Program, joins the Cancer Advances podcast to discuss the program and how patients and caregivers benefit. Listen as she highlights the programs interactive approach to cancer support, the peer-to-peer matching process, and how you can get involved.
playlist_add
Mar 4, 2021
Best Practices for Pediatric Cancer Patients with Autism Spectrum Disorder (ASD)
Rabi Hanna, MD, Chair of Pediatric Hematology, Oncology and Blood and Marrow Transplantation at Cleveland Clinic Children's joins the Cancer Advances podcast to discuss best practices for treating pediatric and young adult cancer patients with autism spectrum disorder (ASD). Listen as Dr. Hanna discusses how we treat the patient, not the disease. By making simple adjustments and individualizing therapy can make a significant difference in a patients treatment.
playlist_add
Feb 25, 2021
Central Nervous System (CNS) Lymphoma Transplant Program
Cleveland Clinic oncologist, Allison Winter, MD, joins the Cancer Advances podcast to discuss Cleveland Clinic's Central Nervous System (CNS) Lymphoma Transplant Program. Listen as Dr. Winter covers how the program started, our multidisciplinary approach to care and which patients with primary CNS lymphoma might benefit most.
playlist_add
Feb 18, 2021
Our Integrative Approach to Palliative Care
Cleveland Clinic Cancer Center Hospice and Palliative Care Specialist, Cory Chevalier, MD, joins the Cancer Advances podcast to discuss palliative care. Listen as Dr. Chevalier discusses our unique model in how we integrate palliative care by using a multidisciplinary approach in both an inpatient and clinical setting.
playlist_add
Feb 11, 2021
HIPEC in Gynecologic Cancers
Robert DeBernardo, MD, Section Head of Gynecologic Oncology at Cleveland Clinic Ob/Gyn & Women’s Health Institute joins the Cancer Advances podcast to discuss hyperthermic intra-peritoneal chemotherapy (HIPEC), specifically in gynecologic cancers. Listen as Dr. DeBernardo discusses the procedure and use of HIPEC along with the type of patient and cancers that are ideal for HIPEC treatment.
playlist_add
Feb 4, 2021
Distinguishing Brain Tumor Progression from Radiation Necrosis
Samuel Chao, MD, radiation oncologist in the Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center of Cleveland Clinic Neurological Institute and Cleveland Clinic Cancer Center, joins the Cancer Advances podcast to talk about the work he recently presented at the American Society of Radiation Oncology (ASTRO) 2020 Annual Meeting. Listen as Dr. Chao discusses preliminary results from a recent Cleveland Clinic study that demonstrate that 18F-fluciclovine PET/CT has the potential to distinguish radiation necrosis from tumor progression in brain tumors previously treated with stereotactic radiosurgery (SRS).
playlist_add
Jan 28, 2021
Managing Sarcoma
Cleveland Clinic Center Director for Musculoskeletal Oncology, Nathan Mesko, MD, joins the Cancer Advances podcast to discuss how Cleveland Clinic is managing sarcoma and cancers involving the bone and soft tissue. Listen as Dr. Mesko covers time to treat in sarcoma patients, the breadth of specialties involved in our multidisciplinary approach to care and how we are collaborating with other Institutions through our national tumor registry.
playlist_add
Jan 21, 2021
IsoPSA Test
Eric Klein, MD, Chairman of Cleveland Clinic’s Glickman Urological & Kidney Institute joins the Cancer Advances podcast to discuss the IsoPSA Test, now being offered at Cleveland Clinic. The IsoPSA test is a novel prostate-specific antigen assay for patients with a PSA > 4ng/ml who are facing a decision on prostate biopsy. Listen as Dr. Klein discusses how the IsoPSA test differs from conventional PSA testing and how your patients can benefit.
playlist_add
Jan 14, 2021
Our Approach to Rare Cancers
Sudipto Mukherjee, MD, MPH, Director of Rare Cancers and Blood Diseases at Cleveland Clinic, joins the Cancer Advances podcast to discuss our approach to rare cancers. Patients with rare cancers and blood diseases often have difficulty finding clinicians with necessary expertise. Listen as Dr. Mukherjee discusses how Cleveland Clinic Cancer Center's Rare Cancers and Blood Diseases initiative uses a multidisciplinary approach that includes a highly sub-specialized team of medical and radiation oncologists, surgeons, radiologists and pathologists.
playlist_add
Jan 7, 2021
Preventing and Treating Hereditary Colorectal Cancer
Just like traits such as eye color or height, an increased risk to form certain types of cancers can also be genetic. Approximately 5% of all colorectal cancer cases are hereditary, and Dr. David Liska, Director of Cleveland Clinic's Sanford R. Weiss, MD Center for Hereditary Colorectal Neoplasia, joins Cancer Advances to discuss these cancers and how the multidisciplinary team at The Weiss Center is dedicated to preventing, treating, and educating patients and their families.
playlist_add
Dec 30, 2020
ASCO GI Review and The Impact of Clinical Trials
Alok Khorana, MD, Director of The Gastrointestinal Malignancies Program and Vice Chair for Career Academic Development at Cleveland Clinic, joins the Cancer Advances podcast to discuss some of his key takeaways from ASCO 2020, along with the important role clinical trials play in cancer advancements, especially GI cancers.
playlist_add
Dec 23, 2020
Target Therapies for Lung Cancer
Newer therapies are not only allowing us to care for our cancer patients better, but oftentimes, it helps increase lifespans with fewer toxicities. Laurie Matt-Amaral, MD, MPH, who specializes in Hematology Oncology at Cleveland Clinic Akron General’s McDowell Cancer Center, joins the Cancer Advances podcast to discuss target therapies for lung cancer. Listen as Dr. Matt-Amaral shares her insights into novel strategies that are evolving with genetic driver mutations and how immunotherapy is changing the way we treat metastatic disease patients.
playlist_add
Dec 17, 2020
Myeloma Management & Navigating Regional Oncology
Cleveland Clinic Cancer Center regional medical oncologist, Kasra Karamlou, MD, joins the Cancer Advances podcast to discuss the management of myeloma and how regional facilities collaborate with main campus to bring the same high level care to their patients locally.
playlist_add
Dec 10, 2020
Merkel Cell Carcinoma
Brian Gastman, MD, Plastic Surgeon and Medical and Surgical Director of the Melanoma and High-risk Skin Cancer Program at Cleveland Clinic, joins Cancer Advances to discuss the latest in Merkel Cell Carcinoma. He touches on treatment options, research and results, along with what we can expect to see in the coming years.
playlist_add
Dec 3, 2020
Minimally Invasive Surgical Approaches
Conor Delaney, MD, PhD, President and CEO of the Cleveland Clinic Florida region, joins the Cancer Advances podcast to discuss minimally invasive surgery (MIS). Listen as Dr. Delaney shares his insight on which patients and types of cancer benefit most from MIS, the importance of a multidisciplinary team and what referring physicians should look for when considering who should do their patient's surgery.
playlist_add
Nov 25, 2020
Single-Fraction Stereotactic Body Radiation Therapy (SBRT) Effective for Early Stage Lung Cancer
Single-fraction SBRT is safe and effective in treating early stage, medically inoperable NSCLC, according to a ten-year retrospective study of 229 patients, the largest single-institution report to date. Gregory Videtic, MD, radiation oncologist at Cleveland Clinic Cancer Center, joins the Cancer Advances podcast to discuss the findings that were presented at the American Society for Radiation Oncology (ASTRO) annual meeting.
playlist_add
Nov 19, 2020
Cleveland Clinic Cancer Center's CHIP Clinic
Cleveland Clinic hematologist/oncologist, Bhumika Patel, MD, joins the Cancer Advances podcast to discuss Cleveland Clinic Cancer Center's new CHIP Clinic. The CHIP Clinic screens and monitors patients with clonal hematopoiesis of indeterminate potential (CHIP): somatic mutations in blood or bone marrow cells that increase the risk of blood cancers and heart disease. Listen as Dr. Patel shares how she believes the CHIP Clinic will implicate how we treat patients moving forward, including cancer survivors.
playlist_add
Nov 12, 2020
The Latest in Breast Cancer Clinical Trials
Jame Abraham, MD, Chair of the Department of Hematology and Medical Oncology at the Cleveland Clinic Cancer Center, joins the Cancer Advances podcast to discuss the latest in breast cancer clinical trials. Listen as Dr. Abraham shares his insight on how to get the word out to patients about clinical trials, the role COVID-19 has played in trial logistics, along with which trials he thinks are likely to have the biggest impact in how we treat patients with breast cancer.
playlist_add
Nov 5, 2020
Leadership Development in Cancer Care
John Suh, MD, Chair of the Department of Radiation Oncology at Cleveland Clinic Cancer Center, joins the Cancer Advances podcast to discuss leadership development. Dr. Suh shares his personal journey on becoming a leader. He highlights the important role coaching and mentorship, self-reflection and emotional intelligence has in continuous improvement.
playlist_add
Oct 29, 2020
The Evolution of Breast Cancer Radiation
Chirag Shah, MD, Director of Breast Radiation and Clinical Research in the Department of Radiation Oncology at Cleveland Clinic, joins the Cancer Advances podcast to discuss the latest in breast cancer radiation. Dr. Shah shares how radiation for the breast has evolved over the past decade, giving breast cancer patients multiple options for radiation treatment. Listen as Dr. Shah discusses how we use a multidisciplinary approach when establishing which type of radiation is best suited for our patients.
playlist_add
Oct 22, 2020
The Latest in Genetic Testing and Screening among Gynecologic Cancer Patients
Genetic testing and screening in gynecologic cancer patients has evolved over the last several years. Miriam AlHilli, MD joins the Cancer Advances podcast to discuss the latest in genetic testing, screening and prevention.
playlist_add
Oct 15, 2020
Screening Guidelines and Incidence Rates for Colorectal Cancer
Colorectal cancer is typically the second or third leading cause of cancer-related death in the United States. Scott Steele, MD, Chair of Colorectal Surgery at Cleveland Clinic joins the podcast to discuss updated screening guidelines and recommended methods, as well as the alarming increase in early-onset colorectal cancer.
playlist_add
Oct 8, 2020
Insights from Cleveland Clinic’s Breast Cancer Survivorship Program
Upon completing cancer treatment, a patient’s journey is truly just beginning. Halle Moore, MD, Director of Breast Medical Oncology and Co-Director of the Comprehensive Breast Cancer Program discusses Cleveland Clinic’s breast cancer survivorship program. Listen as Dr. Moore shares her learnings from more than a decade of research to improve the quality of life for cancer survivors.
playlist_add
Oct 1, 2020
Breakthroughs in Bladder Cancer Research
Cleveland Clinic Cancer Center oncologist Shilpa Gupta, MD discusses promising findings in the treatment of advanced bladder cancer in this week's Cancer Advances podcast. Dr. Gupta shares data from the phase II Bladder Cancer Signal Seeking Trial (BLASST-1), recently presented at the American Society of Clinical Oncology’s Genitourinary Cancers Symposium. She also provides an update on additional in-progress clinical trials and what’s on the horizon for bladder cancer research.
playlist_add
Sep 24, 2020
An Inside Look into the New World of Virtual Visits for Cancer Patients
With the onset of the global pandemic in early 2020, we were fast tracked into the world of virtual visits in order to continue seeing cancer patients who were hesitant or unable to seek in-person care. James Stevenson, MD, Vice-Chair of the Department of Hematology and Medical Oncology in the Taussig Cancer Institute discusses how virtual visits are transforming the way we deliver cancer care for patients. He touches on the benefits for both patients and providers, the best platforms to use, and what’s on the horizon as we continue to utilize this ever-evolving technology.
playlist_add
Sep 17, 2020
Advances in Lobular Breast Cancer Research
Invasive lobular breast cancer accounts for approximately 10-15% of all invasive breast cancer cases and is the second most commonly diagnosed type of invasive breast cancer. Megan Kruse, MD joins the podcast to discuss ongoing and upcoming research to identify optimal treatment plans and outcomes for patients fighting this disease.
playlist_add
Sep 10, 2020
Immunotherapy and Precision Immuno-Oncology
Timothy Chan, MD, Director of our new Center for Immunotherapy and Precision Immuno-Oncology, joins us to discuss his vision to help advance immunotherapy, developmental therapeutics and research at Cleveland Clinic both in Northeast Ohio as well as at our regional sites in Florida, Abu Dhabi and eventually London. Dr. Chan discusses his vision on collaborating and breaking down silos not only internally at Cleveland Clinic for the benefit of patients but more widely across NCI cancer centers and with industry.
playlist_add
Aug 20, 2020
Our Response to Caring for Cancer Patients during the COVID-19 Pandemic
Matt Kalaycio, MD, Vice-Chair of the Taussig Cancer Institute joins us to discuss how we’ve adjusted the way we deliver care to cancer patients during a global pandemic. He touches on how we’re protecting our patients and caregivers, how we quickly adapted our cancer center to promote social distancing, appropriate use of PPE and proper screening, the increase use of virtual visits and the importance of patients to not delay screenings and continue to seek care in a safe way.
playlist_add
Aug 20, 2020
Innovations in Cancer Screening and Accuracy
A prototype blood-based screening test evaluated by Cleveland Clinic researchers and other experts can accurately identify the presence and originating site of 12 high-mortality cancer types, across all stages of progression, with a low false-positive rate, according to the latest results of an ongoing national clinical trial. Eric Klein, MD, Chairman of Cleveland Clinic’s Glickman Urological & Kidney Institute and the co-principal investigator of Cleveland Clinic’s portion of the study joins the Cancer Advances podcast to discuss this trial and the path forward to further validate this multi-cancer detection approach.
playlist_add
Aug 20, 2020
Reducing Time to Treatment for Cancer Patients
Imagine yourself in your patients’ shoes, feeling the anxiety and fear of having just been diagnosed with cancer. Now imagine being told it’s going to take 6 weeks or longer before you’re able to receive treatment. Brian J. Bowell, MD, Chairman of Cleveland Clinic Taussig Cancer Institute, discusses how reducing time to treatment became a vision for him and how he helped inspire our cancer center teams to share best practices and reduce time to treat over the past several years. He discusses barriers we still need to tackle and provides recommendations on how other cancer centers can help make progress on this critical issue.
playlist_add